WELCH DANIEL G has filed 21 insider transactions across 4 companies since February 2023.
Most recent transaction: a grant/award of 51804 shares of Structure Therapeutics Inc. ($GPCR) on June 23, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 23, 2025 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Not found | A | Share Option (right to buy) | 51804 | $0.00 | 51,804.0000 | 172,051,000 | 9999.99% | 0.03% |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | WELCH DANIEL G | Not found | A | Common Stock | 5740 | $0.00 | 32,690.0000 | 90,538,118 | 21.30% | 0.01% |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | WELCH DANIEL G | Not found | A | Stock Option (Right to Buy) | 10787 | $0.00 | 10,787.0000 | 90,538,118 | 9999.99% | 0.01% |
| May 14, 2025 | PROTHENA CORP PUBLIC LTD CO | $PRTA | WELCH DANIEL G | Not found | A | Stock Option (Right to Buy) | 20183 | $0.00 | 20,183.0000 | 53,772,000 | 9999.99% | 0.04% |
| June 25, 2024 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Not found | A | Share Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 139,710,000 | 9999.99% | 0.03% |
| June 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | WELCH DANIEL G | Not found | A | Stock Option (Right to Buy) | 9900 | $0.00 | 9,900.0000 | 73,543,862 | 9999.99% | 0.01% |
| June 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | WELCH DANIEL G | Not found | A | Common Stock | 5345 | $0.00 | 26,950.0000 | 73,543,862 | 24.74% | 0.01% |
| May 24, 2024 | Nuvation Bio Inc. | $NUVB | WELCH DANIEL G | Not found | M | Class A Common Stock | 366744 | $1.64 | 659,947.0000 | 0 | 125.08% | 0.00% |
| May 24, 2024 | Nuvation Bio Inc. | $NUVB | WELCH DANIEL G | Not found | M | Class A Common Stock | 293203 | $1.74 | 293,203.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | Nuvation Bio Inc. | $NUVB | WELCH DANIEL G | Not found | M | Stock Option (Right to Buy) | 293203 | $0.00 | 19,547.0000 | 0 | 93.75% | 0.00% |
| May 24, 2024 | Nuvation Bio Inc. | $NUVB | WELCH DANIEL G | Not found | M | Stock Option (Right to Buy) | 366744 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 15, 2024 | PROTHENA CORP PUBLIC LTD CO | $PRTA | WELCH DANIEL G | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 53,216,000 | 9999.99% | 0.03% |
| Feb. 21, 2024 | PROTHENA CORP PUBLIC LTD CO | $PRTA | WELCH DANIEL G | Not found | A | Stock Option (Right to Buy) | 132000 | $0.00 | 132,000.0000 | 53,216,000 | 9999.99% | 0.25% |
| Aug. 3, 2023 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Director | J | Stock option (right to buy) | 411000 | $7.97 | 973,622.0000 | 114,759,000 | 29.68% | 0.36% |
| Aug. 3, 2023 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Director | J | Stock option (right to buy) | 205500 | $7.97 | 973,622.0000 | 114,759,000 | 26.75% | 0.18% |
| Aug. 3, 2023 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Director | J | Stock option (right to buy) | 205500 | $7.97 | 973,622.0000 | 114,759,000 | 26.75% | 0.18% |
| June 7, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | WELCH DANIEL G | Director | A | Common Stock | 3860 | $0.00 | 21,605.0000 | 69,914,225 | 21.75% | 0.01% |
| June 7, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | WELCH DANIEL G | Director | A | Stock Option (Right to Buy) | 7110 | $0.00 | 7,110.0000 | 69,914,225 | 9999.99% | 0.01% |
| May 15, 2023 | Nuvation Bio Inc. | $NUVB | WELCH DANIEL G | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Director | C | Ordinary Shares | 123508 | $0.00 | 123,508.0000 | 9,584,000 | 9999.99% | 1.29% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | WELCH DANIEL G | Director | C | Series B Preferred Shares | 123508 | $0.00 | 0.0000 | 9,584,000 | 100.00% | 1.29% |